Reduced cortical γ-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy

Archives of General Psychiatry

Volumn 56, Issue 11, 1999, Pages 1043-1047

  Sanacora, Gerard ^a,c   Mason, Graeme F ^a,b   Rothman, Douglas L ^a   Behar, Kevin L ^a   Hyder, Fahmeed ^a   Petroff, Ognen A C ^a   Berman, Robert M ^a   Charney, Dennis S ^a   Krystal, John H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c Yale University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GABAERGIC SYSTEM; HUMAN; MALE; OCCIPITAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; SEX DIFFERENCE;

ADULT; AGE FACTORS; CEREBRAL CORTEX; DEPRESSIVE DISORDER; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OCCIPITAL LOBE; SEX FACTORS;

EID: 0032748780     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.56.11.1043     Document Type: Article

References (40)

1. Kessler RC, McGonagle KA, Zhao S. Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8-19.
2. Petty F. GABA and mood disorders: a brief review and hypothesis. J Affect Disord. 1995;34:275-281.
3. Borsini F, Mancinelli A, D'Aranno V, Evangelista S, Meli A. On the role of endogenous GABA in the forced swimming test in rats. Pharmacol Biochem Behav. 1988;29:275-279.
4. Acosta GB, Losada MEO, Rubio MC. Area-dependent changes in GABAergic function after acute and chronic cold stress. Neurosci Lett. 1993;154:175-178.
5. Acosta GB, Rubio MC. GABAA receptors mediate the changes produced by stress on GABA function and locomotor acitivty. Neurosci Lett. 1994;176:29-31.
6. Sherman AD, Petty F. Neurochemical basis of the action of antidepressants on learned helplessness. Behav Neural Biol. 1980;30:119-134.
7. Petty F, Sherman AD. GABAergic modulation of learned helplessness. Pharmacol Biochem Behav. 1981;15:567-570.
8. Petty F, Trivedi MH, Fulton M, Rush AJ. Benzodiazepines as antidepressants: does GABA play a role in depression? Biol Psychiatry. 1995;38:578-591.
9. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Treviño ES, Risch SC, Goodnick PJ, Morris DD, for the Depakote Mania Study Group. Efficacy of divalproex vs lithium and placebo in the treatment of mania [published correction appears in JAMA. 1994;271:1830]. JAMA. 1994;271:918-924.
10. Weiss E, Brunner H, Clerc G, Guibert M, Orofizimma B, Pagot R, Robert G, Thilliez D, Musch B. Multicenter double-blind study of progabide in depressed patients. In: Bartholini G, Lloyd KG, Morselli PL, eds. LERS Monograph Series. New York, NY: Raven Press; 1986;127-133.
11. Perris C, Tjallden G, Bossi L, Perris H. Progabide versus nortriptyline in depression: a controled trial. In: Bartholini G, Lloyd KG, Morselli PL, eds. LERS Monograph Series. New York, NY: Raven Press; 1986:135-138.
12. Davis LL, Kabel D, Patel D, Choate AD, Foslien-Nash C, Gurguis GN, Kramer GL, Petty F. Valproate as an antidepressant in major depressive disorder. Psychopharmacol Bull. 1996;32:647-652.
13. Petty F, Kramer GL, Dunnam D, Rush AJ. Plasma GABA in mood disorders. Psychopharmacol Bull. 1990;26:157-161.
14. Gold B, Bowers, MB, Roth RH, Sweeney, DW. GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry. 1980;137:362-364.
15. Gerner R, Hare TA. CSF GABA levels in normal subjects and patients with depression, schizophrenia, mania and anorexia nervosa. Am J Psychiatry. 1981;138:1098-1101.
16. Gemer R, Fairbanks L, Anderson M, Young JG, Scheinin M, Linnoila M, Hare TA, Shaywitz BA, Cohen DJ. CSF neurochemistry in depressed, manic and schizophrenic patients compared with normal controls. Am J Psychiatry. 1984;141:1533-1540.
17. Kasa K, Otsuki S, Yamamoto M, Sato M, Kuroda H, Ogawa N. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders. Biol Psychiatry. 1982;17:877-883.
18. Hare TA, Wood JH, Manyam BV, Gerner RH, Ballenger JC, Post RM. Central nervous system gamma-aminiobutyric acid activity in man. Arch Neurology. 1982; 39:247-249.
19. 1H NMR spectra of human brain. Magn Reson Med. 1994;32:294-302.
20. 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci U S A. 1993;90:5662-5666.
21. Petroff OA, Rothman DL, Behar KL, Mattson RH. Low brain GABA level is associated with poor seizure control. Ann Neurol. 1996;40:908-911.
22. 1H-NMR spectra of alcohol dependent and hepatic encephalopathy patients. Am J Psychiatry. 1999;156:952-954.
23. Schutte KK, Hearst J, Moos RH. Gender differences in the relations between depressive symptoms and drinking behavior among problem drinkers: a three-wave study. J Consult Clin Psychol. 1997;65:392-404.
24. Mendez MF, Cummings JL, Benson DF. Depression in epilepsy: significance and phenomenology. Arch Neurol. 1986;43:766-770.
25. American Psychiatric Association. Diagnostic ana Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
26. First M, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. Patient ed. New York: Biometric Research Department, New York State Psychiatric Institute; 1995.
27. Shen J, Rycyna RE, Rothman DL. Improvements on an in vivo automatic shimming method (FASTERMAP). Magn Reson Med. 1997;38:834-839.
28. Gruetter R. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med. 1993;29:804-811.
29. Petroff OA, Rothman DL, Behar KL, Mattson RH. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain. Epilepsia. 1995;36:457-464.
30. Behar K, Rothman DL, Spencer DO, Petroff OAC. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med. 1994;32:294-302.
31. Petroff OA, Spencer DD, Alger JR. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for eilepsy. Neurology. 1989;39:1197-1202.
32. Petty F, Kramer GL, Gullion CM, Rush AJ. Low plasma gamma-aminobutyric acid levels in male patients with depression. Biol Psychiatry. 1992;32:354-363.
33. Erecinska M, Nelson D, Daikhin Y, Yudkoff M. Regulation of GABA level in rat brain synaptosomes: fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies. J Neurochem. 1996;67:2325-2334.
34. Segovia G, Del Arco A, Mora F. Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/ kainate receptors in striatum of the freely moving rat: a microdialysis study. J Neurochem. 1997;69:1476-1483.
35. Martin DL, Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem. 1993;60:395-407.
36. Erecinska M, Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol. 1990;35:245-296.
37. Stayer C, Meinck HM. Stiff-man syndrome: an overview. Neurologia. 1998;13: 83-88.
38. Jackson MC, Scollard DM, Randall JM, Lenney JF. Localization of a novel pathway for the liberation of GABA in the human CNS. Brain Res Bull. 1994;33:370-385.
39. Rothman DL, Behar KL, Prichard JW, Petroff OAC. Homocarnosine and the measurement of neuronal pH in patients with epilepsy. Magn Reson Med. 1997;38:924-929.
40. Post RM, Ballenger JC, Hare TA, Goodwin FK, Lake CR, Jimerson DC, Bunney JR. Cerebrospinal fluid GABA in normals and patients with affective disorders. Brain Res Bull. 1980;5:755-759.